India — Havas Life Mumbai and Shobiz have joined forces to provide integrated experiential solutions for healthcare and pharmaceutical brands in India.
The partnership seeks to combine Havas Life Mumbai’s expertise in medical communications with Shobiz’s experience in large-scale experiential design and execution. According to the agencies, the collaboration is intended to address a gap in the market between scientific knowledge and immersive, outcome-driven engagement.
The joint offering is also expected to include next-generation engagement tools such as VR, AR, and MR simulations, AI-powered interactive platforms, and data-driven engagement solutions, aiming to enhance impact and effectiveness across the healthcare sector.
Charles Houdoux, global chief client officer Havas Health and CEO APAC-LATAM, said, “This collaboration is not simply about communication or events — it is about building a new paradigm where knowledge, emotion, and experience converge to accelerate the understanding and adoption of innovation.”
Rana Barua, group CEO, Havas India, SEA & North Asia, added, “This partnership enables us to move beyond traditional engagement and create truly differentiated, more desirable experiences for the world of health & wellness. This is the future of experiential healthcare in India, and we are proud to be leading it.”
Moreover, Dorelle Kulkarni, managing director, Havas Life Mumbai, commented, “Our partnership with Shobiz brings together deep medical intelligence with world-class experiential capability, allowing us to create transformative, insight-led engagements that are impactful and measurable.”
On the other hand, Sameer Tobaccowala, CEO, Shobiz, added, “By combining Shobiz’s legacy of delivering large-scale, technology-driven experiential solutions with Havas Life Mumbai’s deep understanding of the healthcare ecosystem, we are uniquely positioned to offer clients truly integrated and compliant engagement platforms that deliver tangible business outcomes and move the industry forward.”
The agencies said the partnership is designed to enhance experiential engagement in India’s healthcare and pharmaceutical sector, providing solutions that are scientifically credible, creative, compliant, and measurable.
